Smead Capital Management, Inc. Johnson & Johnson Transaction History

Smead Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $32.9 Million - $36.8 Million	-259,139 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$131.15 - $144.24 $986,248 - $1.08 Million	-7,520 Reduced 2.82%	259,139 $36.1 Million
Q1 2019 May 09, 2019	SELL	$125.72 - $139.79 $1.02 Million - $1.14 Million	-8,132 Reduced 2.96%	266,659 $37.3 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $1.5 Million - $1.81 Million	-12,221 Reduced 4.26%	274,791 $35.5 Million
Q3 2018 Oct 23, 2018	SELL	$121.58 - $142.88 $877,807 - $1.03 Million	-7,220 Reduced 2.45%	287,012 $39.7 Million
Q2 2018 Jul 24, 2018	SELL	$119.4 - $131.76 $628,760 - $693,848	-5,266 Reduced 1.76%	294,232 $35.7 Million
Q1 2018 May 04, 2018	SELL	$125.1 - $148.14 $13,010 - $15,406	-104 Reduced 0.03%	299,498 $38.4 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $1.84 Million - $2.01 Million	-14,013 Reduced 4.47%	299,602 $41.9 Million
Q3 2017 Nov 06, 2017	BUY	$129.47 - $135.38 $40.6 Million - $42.5 Million	313,615	313,615 $40.8 Million

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Smead Capital Management, Inc. with notifications on news.